We speculate that during the development of AMD, RPE dysfunction and elevated levels of FOXC1 transcription factors may regulate the expression levels of PRDM16, RDH11, and RLBP1 in response to retinal oxidative stress. Here, PRDM16 is linked to age-related macular degeneration.